You are now viewing 1 - 5 of 5 results
September 1, 2011 | Journal Article
Using market exclusivity to promote pharmaceutical innovation can lead to positive outcomes, but the practice is also characterized by waste and collateral effects.
January 5, 2011 | Story
Aaron Kesselheim's New England Journal of Medicine article explores 'myths' about effectiveness of policies aimed at incentivizing development of new drugs.
June 21, 2012 | Journal Article
Biomarkers may prove important in medicine, but controversy about biomarker patents has increased in recent years.
February 24, 2009 | Journal Article
Traditional thinking on regulatory law is that regulations arise in large part from crises. The authors propose a more nuanced view, that crises require reframing to the public and control of the narrative to act as spurs for policy.
March 21, 2007 | Journal Article
This study sets out to determine the accessibility and quality of the data available in two states where payment information is made available to the public, Vermont and Minnesota.